Prognostic value of pretreatment 18F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
In Young Jo, Seok-Hyun Son, Myungsoo Kim, Soo Yoon Sung, Yong Kyun Won, Hye Jin Kang, So Jung Lee, Yong-An Chung, Jin Kyoung Oh, Chul-Seung Kay
Radiat Oncol J. 2015;33(3):179-187. Published online 2015 Sep 30 DOI: https://doi.org/10.3857/roj.2015.33.3.179
Citations to this article as recorded by 
Total Lesion Glycolysis on 18F-FDG PET/CT Is a Better Prognostic Factor Than Tumor Dose on 90Y PET/CT in Patients With Hepatocellular Carcinoma Treated With 90Y Transarterial Radioembolization
Sang Hyun Hwang, Hye-Suk Hong, Dongwoo Kim, Gyoung Min Kim, Hye Won Lee, Misu Lee, Do Young Kim, Mi-Ae Park, Mijin Yun
Clinical Nuclear Medicine.2022; 47(6): e437. CrossRef
Radiomics analysis of pre-treatment F-18 FDG PET/CT for predicting response to transarterial radioembolization in liver tumors
Nazım COŞKUN, Alptuğ Özer YÜKSEL, Murat CANYİĞİT, Elif ÖZDEMİR
Journal of Health Sciences and Medicine.2022; 5(4): 1156. CrossRef
Portal vein thrombosis in patients with chronic liver diseases: From conventional to quantitative imaging
C. Sofia, A. Cattafi, S. Silipigni, P. Pitrone, M.L. Carerj, M.A. Marino, A. Pitrone, G. Ascenti
European Journal of Radiology.2021; 142: 109859. CrossRef
Emerging role of18F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinoma
Sang Mi Lee, Hong Soo Kim, Sangheun Lee, Jeong Won Lee
World Journal of Gastroenterology.2019; 25(11): 1289. CrossRef
Recent advances in PET probes for hepatocellular carcinoma characterization
Luca Filippi, Orazio Schillaci, Oreste Bagni
Expert Review of Medical Devices.2019; 16(5): 341. CrossRef
Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with combined hepatocellular-cholangiocarcinoma
Chae Hong Lim, Seung Hwan Moon, Young Seok Cho, Joon Young Choi, Kyung-Han Lee, Seung Hyup Hyun
European Journal of Nuclear Medicine and Molecular Imaging.2019; 46(8): 1705. CrossRef
Preparation and preliminary bioevaluation of 68Ga-oxine in lipiodol as a potential liver imaging agent
Subhajit Ghosh, Tapas Das, Haladhar D. Sarma, Sharmila Banerjee
Journal of Radioanalytical and Nuclear Chemistry.2017; 311(1): 263. CrossRef
Risk stratification for locally advanced hepatocellular carcinoma using pretreatment alpha‐foetoprotein and 18F‐fluoro‐2‐deoxyglucose positron emission tomography
Woo Joong Rhee, Sang Hyun Hwang, Hwa Kyung Byun, Mijin Yun, Kwang‐Hyub Han, Jinsil Seong
Liver International.2017; 37(4): 592. CrossRef
Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis
Dae Yong Kim, Joong-Won Park, Tae Hyun Kim, Bo Hyun Kim, Sung Ho Moon, Sang Soo Kim, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Chang-Min Kim
Radiotherapy and Oncology.2017; 122(1): 122. CrossRef
Pretreatment metabolic parameters measured by 18F-FDG-PET to predict the outcome of first-line chemotherapy in extensive-stage small-cell lung cancer
Xiaozhou Yu, Yanjia Zhu, Jian Wang, Xiuyu Song, Lei Zhu, Xiaoyuan Men, Xiaofeng Li, Dong Dai, Wengui Xu
Nuclear Medicine Communications.2017; 38(2): 193. CrossRef
Radiological biomarkers for assessing response to locoregional therapies in hepatocellular carcinoma: From morphological to functional imaging
Xiao-Dan Ye, Zuguo Yuan, Jian Zhang, Zheng Yuan
Oncology Reports.2017; 37(3): 1337. CrossRef
Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial
Jeong Il Yu, Hee Chul Park, Dongryul Oh, Jae Myoung Noh, Sang Hoon Jung, Hye Yeong Kim, Sung Wook Shin, Sung Ki Cho, Dong Hyun Sinn, Yong-Han Paik, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
International Journal of Hyperthermia.2016; 32(3): 331. CrossRef